title: The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient.
authors.affiliation: 1 Department of Gastroenterology and Hepatology, Digestive Disease Institute Cleveland Clinic Foundation Cleveland, OH 2 Department of Hepatopancreatobiliary and Transplant Surgery, Digestive Disease Institute, Cleveland Clinic Foundation Cleveland, OH 3 Department of Infectious Diseases Cleveland Clinic Foundation Cleveland, OH.
authors.forename: Naim
authors.initials: N
authors.lastname: Alkhouri
authors.forename: Gurshawn
authors.initials: G
authors.lastname: Singh
authors.forename: William D
authors.initials: WD
authors.lastname: Carey
authors.forename: John J
authors.initials: JJ
authors.lastname: Fung
authors.forename: Nizar N
authors.initials: NN
authors.lastname: Zein
authors.forename: Bijan
authors.initials: B
authors.lastname: Eghtesad
authors.forename: Alan
authors.initials: A
authors.lastname: Taege
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D060085:Coinfection / Q000188:drug therapy*; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D012008:Recurrence
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; C486464:telaprevir